Tie2/Tek as a Marker for Breast Tumor Angiogenesis
Author Information
Author(s): KG Peters, A Coogan, D Berry, J Marks, JD Iglehart, CD Kontos, P Rao, S Sankar, E Trogan
Primary Institution: Duke University Medical Center
Hypothesis
Does the expression of Tie2/Tek in breast tumor vasculature serve as a marker for evaluating tumor angiogenesis?
Conclusion
The study found that Tie2 expression is significantly higher in breast tumors compared to normal and benign breast tissues, suggesting its potential as a marker for tumor vasculature.
Supporting Evidence
- Tie2 expression was detected in the endothelium of all breast tissues examined.
- The strongest expression of Tie2 was seen in vascular hotspots within the inflammatory infiltrate at the periphery of invasive tumors.
- The proportion of Tie2-positive vessels was significantly higher in breast tumors than in normal breast tissue or benign breast lesions.
Takeaway
This study looked at a special protein called Tie2 in breast cancer and found that it shows up more in tumors than in normal tissue, which could help doctors understand how tumors grow.
Methodology
Immunohistochemistry was used to evaluate Tie2 expression in normal breast tissue, benign lesions, and breast tumors.
Limitations
No significant correlation was found between Tie2 expression and clinical prognostic indicators such as tumor size or lymph node status.
Participant Demographics
Included 10 normal breast specimens, 10 benign lesions, and 123 breast tumors, primarily invasive ductal carcinomas.
Statistical Information
P-Value
0.0001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website